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Background: The evidence suggests that arterial stiffness acts as an independent predictor of 
general as well as cardiovascular mortality, strokes in patients with arterial hypertension, type 2 
diabetes mellitus in the elderly, and in the general population. The oscillometric method measures 
parameters of arterial stiffness by applying special methods of processing oscillograms. This is 
a study of the reproducibility and repeatability of central aortic systolic blood pressure (SBP), 
augmentation index, and reflected wave transit time measured by Vasotens® technology.
Methods: Anthropometric and hemodynamic measurements for 90 volunteers were made by 
two observers using the 24-hour blood pressure monitoring system, BPLab®, with Vasotens 
technology in “office” mode, over a period of two days and always at the same time in the 
morning. Initialization of the device was performed prior to each measurement cycle for each 
participant.
Results: Analysis of short-term repeatability and reproducibility data for central aortic systolic 
blood pressure, reflected wave transit time, and augmentation index did not reveal any   statistically 
significant differences. For observer A, SBP was 0.11 ± 7.53 mmHg and aortic SBP was 
0.26 ± 6.11 mmHg; for observer B, SBP was 0.14 ± 8.42 and aortic SBP was 0.2 ± 7.25 mmHg. 
Short-term reproducibility for the different observers with averaging of both measurements was 
0.36 ± 5.69 mmHg for SBP and 0.37 ± 6.7 mmHg for aortic SBP; the next day, repeatability for 
observer A was 0.52 ± 10.7 mmHg for SBP and 0.73 ± 8.98 mmHg for aortic SBP.
Conclusion: BPLab with Vasotens technology has good reproducibility and repeatability, and 
can be recommended for clinical vascular risk estimation.
Keywords: arterial stiffness, central aortic blood pressure, augmentation index, reflected wave 
transit time, reproducibility, repeatability
Introduction
Cardiovascular disease is among the main determinants of mortality in the general 
population. Thus, identification of risk factors at an early preclinical stage of disease 
is an important issue in cardiology. Several leading research papers over the past 
decade have shown that arterial stiffness is an independent predictor of cardiovascular 
morbidity and mortality in the general population.1–6
Blood vessels are the target organs affected by a number of diseases. Changes 
in the vessel wall occur with arterial hypertension, diabetes mellitus, chronic renal 
insufficiency, atherosclerosis, and aging.7 The process of vessel remodeling includes 
several stages of functional and morphological changes, resulting in disruption of Vascular Health and Risk Management 2011:7 submit your manuscript | www.dovepress.com
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the two main functions of blood vessels, ie, conduction and 
shock absorption.
The conducting function ensures delivery of an adequate 
amount of blood to peripheral tissues according to demand. 
The shock absorbing function enables delivery of a   relatively 
stable blood pressure to peripheral tissues, is based on 
  elasticity of the arteries, and serves to absorb blood pressure 
fluctuations caused by the heart.
Disruption of the shock-absorbing function is caused by 
an increase in artery wall stiffness, which results in increased 
systolic and pulse pressure, decreased diastolic pressure, and 
acceleration of the reflected wave. As a result, left   ventricular 
afterload increases, myocardial hypertrophy develops, 
coronary perfusion worsens, and impaired left ventricular 
diastolic function develops.8 This makes timely diagnosis of 
changes in the vessel wall particularly important.9
Today, although we do have some standard techniques 
that are used widely for estimation of arterial wall stiffness, 
there are new methods in the research stage.10–14 In this regard, 
the oscillometric method is particularly relevant because it 
allows measurement of parameters of arterial stiffness by 
using special oscillographic methods.15 The reliability of 
a device can be verified by testing the reproducibility and 
repeatability of results obtained in everyday clinical use 
by specialists, eg, cardiologists, general practitioners, and 
endocrinologists. The aim of this study was to investigate 
the reproducibility and repeatability of blood pressure and 
arterial stiffness indicators, ie, aortic (central) systolic blood 
pressure (BP), augmentation index, and reflected wave transit 
time, as measured using a 24-hour BP monitoring system, 
ie, BPLab® and Vasotens® technology (Petr Telegin, Nizhny 
Novgorod, Russian Federation).
Materials and methods
Ninety volunteers (45 male and 45 female) of mean age 
44.5 ± 18.92 years (range 18–79 years) agreed to participate 
in this open, single-center, observational study, and gave their 
informed consent to participate. Eleven (12.2%) participants 
had symptoms of hypotension (systolic BP # 110 mmHg, 
diastolic BP # 70 mmHg). Thirteen (14.4%) had symptoms 
of hypertension (systolic BP $ 160 mmHg, diastolic 
BP $ 100 mmHg). Exclusion criteria were atrial   fibrillation, 
severe cardiac anomalies, heart failure, arrhythmia,   presence 
of an artificial pacemaker, pregnancy, or body mass 
index .30.
Measurements were taken independently by two 
  observers, with each volunteer in a comfortable position 
(ambient temperature 22°C–25°C, no sudden noises or other 
exciting stimuli), over a period of 2 days. Measurements 
were taken at the same time in the morning in the recumbent 
position after 10 minutes of relaxation. Alcohol consumption 
was prohibited for 24 hours prior to the measurements, along 
with smoking and caffeinated drinks for 8 hours beforehand, 
and any medicines affecting the cardiovascular system. 
  Volunteers were permitted to have had breakfast no more 
than half an hour before testing.
The two study investigators received adequate training by 
an expert in BP measurement. The devices were initialized 
before measurement. The monitor was uploaded according 
to the measuring protocol as per the BPLab software user’s 
guide. Measurements were performed by pressing the   monitor 
start button. All measurements were carried out using the left 
arm. Five measurements were taken for each volunteer on 
day 1: 0A, observer A, adaptive measurement (excluded 
from the analysis); 1A, observer A, first measurement; 1B, 
observer B, first measurement; 2A, observer A, second mea-
surement; and 2B, observer B, second measurement.
Each measurement included applying and removing 
the cuff with the exception of measurement 1A, which 
was not preceded by removal of the cuff. The interval 
between measurements was 3 minutes. When BP could not 
be   measured (ie, when the device displayed an error signal), 
the measurement was repeated 1 minute later without removal 
of the cuff. Measurements for each volunteer were saved 
in a BPW file (data format used for BPLab devices) using 
BPLabWin software. On the second day, three measurements 
were taken for each volunteer at 3-minute intervals, with 
the first measurement being adaptive, and the second 
and the third one included in the analysis: 3A, observer 
A, first measurement on the second day; 4A, observer A, 
second measurement on the second day; and 5A, observer 
A, third measurement on the second day. The cuff was not 
removed between measurements.
Test parameters
Pulse waves were recorded into the memory of the device 
using a special pneumatic system sensor analyzed by 
BPLabWin software using built-in Vasotens algorithm. 
  Systolic BP is the peak value of the excess blood   pressure 
in the artery at the moment of ventricular systole. In devices 
using the oscillometric method, systolic BP and aortic 
  systolic BP are estimated using algorithms applied to 
analysis of the oscillometric curve and the shape of the 
pressure pulsation.
Reflected wave transit time is the reciprocal of pulse 
wave velocity. The estimation method used for this Vascular Health and Risk Management 2011:7 submit your manuscript | www.dovepress.com
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  parameter is based on identification of the reflected wave 
on the pulse curve by the Vasotens algorithm (Figure 1A). 
This algorithm takes into account the delay of the reflected 
wave relative to the direct wave (specified in Figure 1A as 
reflected wave transit time). The transit time of both the 
direct and the reflected wave is equal to double the length 
of the aortic trunk.
The aortic augmentation index (aAIx) is defined as the 
percentage ratio of the pressure increment caused by the 
reflected wave (AP) to the pulse pressure (PP) in the aorta 
(Figure 1B):
  aAIx = (AP/PP) × 100%
statistical analysis
Analysis of the results was performed using Microsoft 
Excel. Repeatability of the results obtained by one observer 
within a short period of time (intraobserver repeatability) 
was determined by:
 X 1A − X2A  (1A)
 X 1B − X2B  (1B)
Reproducibility of the results obtained by different 
observers within a short period of time (interobserver repro-
ducibility) was determined by:
 X 1A − X1B,  X2A − X2B  (2)
Reproducibility of the averaged measurements taken 
by different observers within a short period of time (inter- 
observer reproducibility) was determined by:
  XXXX 1A 2A 1B 2B
22
++
−
 
(3)
Averaging of the two measurements taken by each of the 
observers decreases the impact of physiological variation 
in the indicators that occurs in each volunteer during the 
test period. This is done in order to separate the subjective 
component caused by particular factors of the   measurements 
as taken by a specific observer. The repeatability of the 
  measurements taken on the next day, shows day-to-day 
variations by the same observer:
 X 1A − X4A,  X2A − X5A  (4)
Repeatability of the results obtained for different 
  measurements is defined by the statistical features of the 
variations between the results of the measurements. These 
were taken on the second day of the study when the   subjective 
component of the margin of error (resulting from the   tightness 
of the cuff) was nullified. Further, in order to estimate the 
variations between the first (adaptive) measurement and 
  further measurements (known as the “first measurement 
effect”), the statistical characteristics of the following 
  variations were calculated separately:
 X 3A − X4A,  (5A)
 X 4A − X5A.  (5B)
Statistical characteristics of variations 1–5 for each of 
the hemodynamic variables were estimated based on the data 
obtained, ie, average ∆X difference values, their standard 
deviations σ∆X, and variations of differences expressed in 
percent values () 100%) / σ∆ ∆ X X ⋅ . Bland–Altman plots were 
constructed for each of the hemodynamic variables. P , 0.05 
was considered to be statistically significant.
Results
Analyses of short-term repeatability and reproducibility 
of peripheral and aortic systolic BP, as well as day-to-day 
RWTT
AP
PP
A
B
Figure 1 Method of RWTT (A) and aortic augmentation index (B) measurement.
Abbreviations: PP, pulse pressure; AP, reflected wave; RWTT, reflected wave 
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data repeatability, did not reveal any statistically significant 
variations. Peripheral systolic BP variation was found to be 
0.11 ± 7.53 mmHg for observer A and −0.14 ± 8.42 mmHg 
for observer B. Short-term reproducibility by different 
observers averaged on the basis of two measurements was 
0.36 ± 5.69 mmHg. Indicators of short-term repeatability 
of aortic systolic BP were 0.26 ± 6.11 mmHg for observer 
A and 0.2 ± 7.25 mmHg for observer B, and the short-term 
reproducibility for the different observers averaged for the 
two measurements was 0.37 ± 8.98 mmHg for aortic systolic 
BP. There were no statistically significant differences in 
measurements for the study parameters (see Table 1).
Analysis of short-term repeatability and reproduc-
ibility as well as reflected wave transit time repeatability 
and   central augmentation index could not be performed on 
the next day for all volunteers. However, no statistically 
  significant variations were found. Reflected wave transit time 
  repeatability was 2.75 ± 14.98 milliseconds for observer A 
and 0.75 ± 16.78 milliseconds for observer B; short-term 
reproducibility for the two different observers averaged on 
the basis of two measurements was −0.95 ± 8.83 milliseconds. 
Short-term repeatability indicators for the aortic augmentation 
index was 2.41% ± 8.12% when measured by observer A 
and −0.4% ± 7.16% when measured by observer B; short-term 
reproducibility for the different observers averaged for two 
measurements was 0.6% ± 4.64%. On the next day, repeatability 
was 1.88 ± 18.9 milliseconds for the reflected wave transit time 
and 1.85% ± 9.1% for aortic augmentation index.
Analysis of Bland–Altman plots based on short-term 
repeatability of the different observers showed that average 
variation was negligible in comparison with the dispersion 
of the variations, most probably caused by physiological 
variability (Figure 2). Comparison of the plots (and of the 
parameters outlined in Table 1) showing the results obtained 
by observers A and B indicates good reproducibility of the 
results (Figure 3). Dispersion of the variations was similar, 
indicating no observer effect.
Comparison of the repeatability diagrams for the different 
observers shows the average of the two measurements and 
also suggests that physiological variability is the principal 
reason for the dispersion of results. On averaging of several 
measurements, dispersion of the variations could be expected 
to decrease, as shown in the diagrams. For instance, if the 
dispersion was caused by device error, no decrease would 
be observed after averaging (Figure 4).
The increase in day-to-day indicators of variation reported 
in Table 1 and shown in the diagrams also attest to the 
domination of physiological variability, which shows a clear 
increase as the interval between the measurements becomes 
longer (Figure 4).
Studies of the “first (adaptive) measurement effect” show 
that such an effect is present, albeit not   statistically   significant. 
Table 1 Repeatability and reproducibility of the measurements data
Indicator (formula) SBP (n = 90) aSBP (n = 90) RWTT (n = 86) aAIx (n = 86)
Average  
(SD),  
(mmHg)
Variation,  
(%)
Average  
(SD),  
(mmHg)
Variation,  
(%)
Average  
(SD),  
(mmHg)
Variation,  
(%)
Average  
(SD),  
(mmHg)
Variation, 
(%)*
intra-observer repeatability,  
observer A (1a)
0.11 
(7.53)
5.8 0.26 
(6.11)
5.2 2.75 
(14.98)
11.2 2.41 
(8.12)
–
intra-observer repeatability,  
observer B (1b)
−0.14 
(8.42)
6.5 0.20 
(7.25)
6.1 0.75 
(16.78)
12.6 −0.40 
(7.16)
–
intra-observer repeatability,  
both observers (1a) + (1b)
−0.02 
(7.96)
6.1 0.23 
(6.68)
5.6 1.77 
(15.85)
11.9 0.98 
(7.75)
–
inter-observer  
reproducibility (2)
0.48 
(7.55)
5.8 0.37 
(6.70)
5.7 −0.84 
(15.88)
11.9 0.81 
(7.58)
–
Averaged inter-observer  
reproducibility (3)
0.36 
(5.69)
4.4 0.37 
(5.10)
4.3 −0.95 
(8.83)
6.6 0.60 
(4.64)
–
Day-to-day  
variations (4) 
0.52 
(10.07)
7.7 0.73 
(8.98)
7.6 1.88 
(18.90)
14.2 1.85 
(9.10)
–
1–2 measurements 
repeatability (5a) 
2.49 
(7.44)
5.7 2.84 
(6.80)
5.7 1.08 
(15.95)
12.0 2.14 
(8.76)
–
2–3 measurements  
repeatability (5b)
0.43 
(6.40)
4.9 0.34 
(5.35)
4.5 2.15 
(13.82)
10.5 0.56 
(8.22)
–
Total repeatability  
(5a) + (5b)
1.46 
(7.00)
5.4 1.59 
(6.23)
5.7 1.57 
(14.97)
11.3 1.35 
(8.51)
–
Note: *This value has no physical sense for aAix as the averaged value of aAix may reduce to zero. 
Abbreviations: SBP, systolic blood pressure; aSBP aortic systolic blood pressure; aAIx, augmentation index; RWTT, reflected wave transit time; SD, standard deviation.Vascular Health and Risk Management 2011:7 submit your manuscript | www.dovepress.com
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Figure 2 intraobserver repeatability of sBP (A) and asBP (B) values measured by one and both observers.
Abbreviations: sBP, systolic blood pressure; asBP, aortic systolic blood pressure.
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Abbreviations: RWTT, reflected wave transit time; SBP, systolic blood pressure; aSBP, aortic systolic blood pressure; aAIx, aortic augmentation index.Vascular Health and Risk Management 2011:7 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
654
Ageenkova and Purygina
−50
80 90 100 110 1201 30
RWTT (milliseconds)
D
a
y
-
t
o
-
d
a
y
 
d
i
f
f
e
r
e
n
c
e
 
(
m
i
l
l
i
s
e
c
o
n
d
s
)
1401 50 1601 70 180
−40
−30
−20
−10
0
10
20
30
40
50
−50
−20 02 04 0
aAIx (%)
D
a
y
-
t
o
-
d
a
y
 
d
i
f
f
e
r
e
n
c
e
 
(
%
)
60 80
−40
−30
−20
−10
0
10
20
30
40
50
−50
80 1001 20 140
aSBP (mmHg)
D
a
y
-
t
o
-
d
a
y
 
d
i
f
f
e
r
e
n
c
e
 
(
m
m
H
g
)
1601 80 200
−40
−30
−20
−10
0
10
20
30
40
50
−50
80 1001 20 140
SBP (mmHg)
D
a
y
-
t
o
-
d
a
y
 
d
i
f
f
e
r
e
n
c
e
 
(
m
m
H
g
)
1601 80 200
−40
−30
−20
−10
0
10
20
30
40
50
Figure 4 Repeatability of day-to-day sBP, asBP, RWTT, and aAix measurement results (day-to-day variations).
Abbreviations: RWTT, reflected wave transit time; SBP, systolic blood pressure; aSBP, aortic systolic blood pressure; aAIx, aortic augmentation index.
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Figure 5 Repeatability of results of different measurements, ie, “first measurement effect”.
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This is evident from comparison of the   repeatability   diagrams 
between the first and second measurements and also between 
the second and third measurements on the second day of 
the test (Figure 5), as well as from the values shown in 
Table 1.
Discussion
The results of numerous reproducibility and repeatability 
studies show that dispersion of statistical variations in results 
of different measurements obtained by different devices is 
quite considerable (Table 2).16–19 According to a study by 
Crilly et al, considerable dispersion of the values obtained 
may be explained by differences in patient inclusion criteria, 
the duration of relaxation preceding the measurements, and 
the experience of the observers, as well as the impact of 
daily variations in parameters measured at different times 
of the day.12 Therefore, no accepted normative values can 
be established for these parameters.
So what is the importance of such studies? It is evident 
that the results for repeatability and reproducibility of the 
measurements obtained for the different hemodynamic 
variables are influenced by at least three factors: natural 
physiological variability of the variables over time, even 
after intervals of several minutes; subjective components, eg, 
differences in the tightness of the cuff applied by different 
observers; and errors caused by the limited accuracy of 
a device, the measurement method used, or flaws in the 
measurement algorithm.
It is also evident that when the impact of the second and 
third factors mentioned above is significantly smaller than the 
first, it is possible to conclude that measurements taken by a 
particular device are objective and can be recommended for use 
in clinical practice. Estimation of the influence of these factors 
is addressed in reproducibility and repeatability studies.
This study of reproducibility and repeatability of 
  measurements for certain hemodynamic variables obtained by 
BPLab devices demonstrates a subjective component based 
on the measurement techniques used by different observers 
(reproducibility). The errors connected with the inaccuracy 
of this device (repeatability) are less significant in relation 
to the objectively presented variability of the measured 
  parameters, both in the short-term and on an ongoing basis. 
This   conclusion is supported by the results of our study.
Twenty-four-hour monitoring using BPLab for measure-
ment of BP and other hemodynamic variables using   Vasotens 
technology has successfully passed   reproducibility and 
repeatability testing, and can be recommended for   vascular 
risk estimation in clinical practice.
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